Accelerating global chemical product innovation and development

Scientific and regulatory support to market and sustain your products in any jurisdiction.

Competitive Advantage

Acta is a global scientific and regulatory consulting firm that assists companies that make and use chemicals with strategic commercialization planning and complex product registration and compliance matters.

We partner with our clients to help them get products quickly and efficiently to market — in any country or locale — and keep them there when challenged by a new regulatory regime, issue, or set of rules.

More About Us

Knowledge & Insights

  July 22, 2024
Memoranda
PFAS – What to Know Now, and What to Expect

Perfluoroalkyl and polyfluoroalkyl substances (PFAS) are attracting global legal, regulatory, commercial, and litigation attention as no other...

  November 20, 2024
Memoranda
MPCA Requests Comments on Planned PFAS in Products Reporting and Fee Rule

On November 18, 2024, the Minnesota Pollution Control Agency (MPCA) requested comments on planned rules governing reporting and fees paid by...

  November 19, 2024
Memoranda
EPA Issues ANPRM under TSCA Section 6 on 6PPD and 6PPD-Quinone

On August 1, 2023, Earthjustice filed a petition under Section 21 of the Toxic Substances Control Act (TSCA) asking the U.S. Environmental Protection...

  November 13, 2024
Memoranda
EPA Administrator Signs Final Rule Revising PBT Rules for decaBDE and PIP (3:1)

On October 31, 2024, U.S. Environmental Protection Agency (EPA) Administrator Michael S. Regan signed a final rule revising the regulations for...

  November 4, 2024
Memoranda
EPA Issues Fifth Test Order for a PFAS

On October 9, 2024, the U.S. Environmental Protection Agency (EPA) announced that it has issued its fifth Toxic Substances Control Act (TSCA) test...

  October 17, 2024
Memoranda
EPA Proposes to Add 16 PFAS and 15 PFAS Categories to the TRI List of Chemicals

The U.S. Environmental Protection Agency (EPA) proposed on October 8, 2024, to add 16 individual per- and polyfluoroalkyl substances (PFAS) and 15...

  October 9, 2024
Memoranda
EPA Seeks Public Comment on Manufacture of Certain PFAS during Fluorination of HDPE and Other Plastic Containers

On September 30, 2024, the U.S. Environmental Protection Agency (EPA) requested public comment on the manufacture of certain per- and polyfluoroalkyl...

Seminars & Webinars

  October 22, 2024
Seminars & Webinars
HCPA 2024 Annual Meeting, December 8-11, 2024, Fort Lauderdale, FL

HCPA’s Annual Meeting engages on the public policy issues that impact the household and commercial products industry. Thought leaders will discuss...

  November 19, 2024
Seminars & Webinars
What to Expect in Chemicals Policy and Regulation and on Capitol Hill in 2025, January 14, 2025, 11:00 a.m. – 12:00 p.m. (EST), via webinar

Registration is now open for Acta and B&C’s “What to Expect in Chemicals Policy and Regulation and on Capitol Hill in 2025” webinar. Lynn...

  December 18, 2023
Seminars & Webinars
Consumer Labeling and the Status of GHS, April 1, 2025, 11:00 a.m. – 12:00 p.m. (EST), via webinar

B&C and Acta are pleased to present “Consumer Labeling and the Status of GHS.” More details will be posted closer to the webinar....

With offices in the U.S., UK, and Europe, and partners and agents in China, South Korea, Turkey, Mexico, and more, Acta offers expertise with regulatory programs and chemical product approvals in North America, Europe, South and Central America, and Asia.

Our Firms

our people

Experienced industry and agency scientists, including organic chemists, toxicologists, exposure experts, seven Ph.D.’s. Government affairs and regulatory specialists including nine high-level EPA alumni. Business strategists with decades of experience directing worldwide regulatory compliance.

Acta consultants manage products from concept to approval, delivering skills and experience with specific product areas in government and industry.

Our three affiliated firms -- B&C, Acta, and BCCM -- provide a full range of global support for the commercialization of chemicals, biocides, and products of industrial biotechnology, nanotechnology, and synthetic biology.